降钙素原与急性冠脉综合征病人病变关系的临床观察被引量：2

导出

摘要目的检测急性冠脉综合征(ACS)病人降钙素原(PCT)、超敏C反应蛋白水平(hsCRP),探讨二者与ACS病人冠状动脉病变程度的关系。方法将因ACS入院的122例病人分为不稳定型心绞痛组(UAP组,60例)、急性心肌梗死组(AMI组,62例),另选取同期住院行冠状动脉造影结果正常的25例病人作为对照组。ACS病人根据病变支数分为单支病变组、双支病变组、三支病变组。分析血清降钙素原、超敏C反应蛋白(hsCRP)水平与病变支数、Gensini积分的关系。结果 PCT、hsCRP水平在单支病变、双支病变、三支病变组间差异无统计学意义(P>0.05),Gensini积分在3组间差异有统计学意义(P<0.05)。PCT和hsCRP水平均与Gensini积分呈正相关(r=0.87,P<0.05;r=0.90,P<0.05)。结论血清PCT、hsCRP的水平与冠状动脉粥样硬化病变程度呈正相关,同时检测PCT和hsCRP有助于早期诊断动脉粥样硬化引起的急性冠脉综合征。

作者王利芳

机构地区山西省阳泉煤业集团总医院

出处《中西医结合心脑血管病杂志》 2016年第13期1517-1519,共3页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease

关键词急性冠状动脉综合征降钙素原超敏C反应蛋白早期诊断病变支数

分类号 R541.4 [医药卫生—心血管疾病] R256.2 [医药卫生—中医内科学]

引文网络
相关文献

参考文献13

1Arazi HC, Badimon JJ. Anti -inflammatory effects of anti - platel et treatment in atherosclerosis[J].Curr Pharm Des, 2012, 18 (28) :4311 - 4325.
2孙利强,陈杰,李恩,刘宗芳,张丽华,简立国.急性冠脉综合征患者血清半乳糖凝集素-3和C反应蛋白水平的变化[J].郑州大学学报（医学版）,2014,49(3):397-400. 被引量：15
3Van Diepen JA, Berbee JF, Havekes LM, et al .Interactions be- tween inflammation and lipid metabolism: relevance for efficacy of anti - inflammatory drugs in the treatment of atherosclerosis [ J]. Atherosclersis, 2013,228(2) : 306.
4Rietzschel E,De Buyzere M. High sensitive reactive protein: universal prognostic and causative biomarker in heart disease [J]. Biomark Med,2012,6(1) : 19 - 34.
5邓石雄.和肽素和降钙素原及其他炎症指标在脑卒中患者发生感染中的预测价值[J].中国老年学杂志,2014,34(8):2048-2050. 被引量：15
6Klingenberg R,Luscher TF. Inflammation in coronary artery dis ease and acute myocardial infarction is the stage set for novel therapies[J]. Curt Pharm Desk2012,18(28) :4358 - 4369.
7Rattazzi M, Puato M, Faggin E, et al. C - reactive protein and in- ter le~kin- 6 in vascular disease: culprits or passive bystanders [J]. J Hypertens,2003,21(10) : 1787- 1803.
8Cho HC, Yu G, Lee MY, et al. TNF - ~ polymorphisms and coro- nary artery disease: association study in the Korean population[J]. Cytokine,2013,62(1): 104- 109.
9Fuchs S,Lavi I, Tzang O, et al. Intracoronary monocyte che- moattractant protein 1 and vascular endothelial growth factor levels areassodated with necrotic core, calcium and fibrous tis- sue atherosclerotic plaque components., an intracoronary ultra- sound radiofrequency study [J].Cardiology,2012,123(2) :125 - 132.
10Laskarin G,Zaputovic L, Persic V, et al .Harmful immune reac- tions during acute myocardial infarction [J].Med Hypotheses, 2012,78 : 703 - 706.

二级参考文献31

1王宪赟,高俊鹏,蔡定芳.急性缺血性卒中肺部感染的预防研究[J].神经病学与神经康复学杂志,2009,6(3):228-231. 被引量：5
2明自强,俞林明,吕银祥,王黎卫,吕少敏.生脉注射液和复方丹参注射液治疗急性脓毒性心肌病疗效观察[J].中国中西医结合急救杂志,2006,13(6):364-366. 被引量：11
3田宝国,王子平,李云.炎症和感染与缺血性脑卒中的关系[J].中国热带医学,2005,5(4):850-852. 被引量：6
4Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med, 2003,31 : 1250-1256.
5Hatherill M, Tibby SM, Turner C, et al. Procalcitonin and cytokine levels:relationship to organ failure and mortality in pediatric septic shock. Crit Care Med,2000,28:2591-2594.
6Tang BM, Eslick GD, Craig JC, et al. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients:systematic review and meta-analysis. Lancet Infect Dis, 2007,7 : 210-217.
7Manana P, Nedelnlkov,4 K, Gurlich R. Physiology and genetics of procalcitonin. Physiol Res, 2000,49 Suppl 1 : $57-61.
8Indino P, Lemarchand P, Bady P, et al. Prospective study on procalcitonin and other systemic infection markers in patients with leukocytosis. Int J Infect Dis, 2008,12 : 319-324.
9Lemeshow S,Teres D, Klar J, et al. Mortality Probability Models (MPM II ) based on an international cohort of intensive care unit patients. JAMA, 1993,270 : 2478-2456.
10Castelli GP,Poqnani C,Cita M,et al. Procalcitonin,C-reactive protein,white blood cells and SOFA score in ICU:diagnosis and monitoring of sepsis. Minerva Anestesiol,2006,72:69-80.